Health Scope Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-07-2024
- Paid Up Capital ₹ 4.10 M
as on 24-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 24-07-2024
- Satisfied Charges ₹ 1.49 Cr
as on 24-07-2024
- Revenue -15.11%
(FY 2023)
- Profit 1040.92%
(FY 2023)
- Ebitda -56.79%
(FY 2023)
- Net Worth 221.72%
(FY 2023)
- Total Assets -7.59%
(FY 2023)
About Health Scope Remedies
The Corporate was formerly known as Health Scope Ramdies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.10 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹1.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vanshdeep Singh and Amanpreet Kaur serve as directors at the Company.
- CIN/LLPIN
U74999PB2018PTC047887
- Company No.
047887
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Zira, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Health Scope Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vanshdeep Singh  | Director | 09-May-2018 | Current |
| Amanpreet Kaur | Director | 23-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Health Scope Remedies.
Health Scope Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.11% decrease. The company also saw a substantial improvement in profitability, with a 1040.92% increase in profit. The company's net worth Soared by an impressive increase of 221.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Health Scope Remedies?
In 2023, Health Scope Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vitawins Private LimitedActive 3 years 2 monthsVanshdeep Singh and Amanpreet Kaur are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 15 Nov 2022 | ₹2.00 Cr | Open |
Uco Bank Creation Date: 02 Mar 2019 | ₹1.49 Cr | Satisfied |
How Many Employees Work at Health Scope Remedies?
Unlock and access historical data on people associated with Health Scope Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Health Scope Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Health Scope Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
